National Healthcare (NHC) Net Equity Issued and Repurchased (2010 - 2026)

National Healthcare (NHC) has 17 years of Net Equity Issued and Repurchased data on file, last reported at $12.3 million in Q1 2026.

• Quarterly Net Equity Issued and Repurchased rose 859.94% year-over-year to $12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.2 million (up 253.29% YoY) and the FY2025 annual result came in at $14.2 million, changed 0.38% from the prior year.
• Net Equity Issued and Repurchased improved to $12.3 million in Q1 2026, from $4.8 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $12.3 million in Q1 2026 to a low of $6000.0 in Q2 2023.
• A 5-year average of $2.9 million and a median of $1.3 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2023 — Net Equity Issued and Repurchased sank 99.46% — and 2024, when it soared 47016.67%.
• Tracing NHC's Net Equity Issued and Repurchased over 5 years: stood at $833000.0 in 2022, then sank by 93.64% to $53000.0 in 2023, then surged by 1403.77% to $797000.0 in 2024, then surged by 502.13% to $4.8 million in 2025, then surged by 155.64% to $12.3 million in 2026.
• The last three Net Equity Issued and Repurchased figures came in at $12.3 million (Q1 2026), $4.8 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.